Alexander S. Kauffman • Jeremy T. Smith
Editors

2013

We were lucky to get into the kisspeptin “ fi eld” during its early days, though we had avenues of entry. In early 2004, Sasha was a postdoctoral fellow in Dr. Emilie Rissman’s lab in Virginia, where he was studying the effects of various reproductive neuropeptides, such as GALP and GnRH variants, on sex behavior. Dr. Rissman asked whether Sasha would be interested in studying sexual behavior and sexual differentiation in a newly created transgenic mouse that was lacking an orphan receptor called GPR54.